CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 34 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $596,000 | -36.1% | 2,590,613 | 0.0% | 0.00% | – |
| Q4 2017 | $933,000 | -27.7% | 2,590,613 | +4.3% | 0.00% | – |
| Q3 2017 | $1,291,000 | -7.8% | 2,483,584 | +2.9% | 0.00% | – |
| Q2 2017 | $1,400,000 | -61.4% | 2,414,475 | +17.9% | 0.00% | – |
| Q1 2017 | $3,626,000 | +62.5% | 2,048,283 | +10.2% | 0.00% | – |
| Q4 2016 | $2,231,000 | +125.6% | 1,858,649 | +101.1% | 0.00% | – |
| Q3 2016 | $989,000 | +3.9% | 924,384 | +1.0% | 0.00% | – |
| Q2 2016 | $952,000 | -6.6% | 915,369 | +8.7% | 0.00% | – |
| Q1 2016 | $1,019,000 | -11.2% | 842,234 | +13.0% | 0.00% | – |
| Q4 2015 | $1,148,000 | -99.3% | 745,443 | -86.5% | 0.00% | -100.0% |
| Q3 2015 | $160,943,000 | +9761.7% | 5,507,340 | +1614.1% | 0.01% | – |
| Q2 2015 | $1,632,000 | – | 321,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAM Investors, LLC | 670,593 | $3,401,000 | 0.45% |
| Prospera Financial Services Inc | 184,100 | $236,000 | 0.05% |
| HighTower Advisors, LLC | 1,047,731 | $1,257,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 15,142 | $18,000 | 0.01% |
| TEACHERS ADVISORS, LLC | 298,781 | $1,820,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 724,455 | $4,412,000 | 0.00% |
| Virtu KCG Holdings LLC | 90,490 | $109,000 | 0.00% |
| FIRST FOUNDATION ADVISORS | 10,000 | $12,000 | 0.00% |
| Acrospire Investment Management LLC | 2,300 | $3,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |